Shares of Sonova Holding (OTCMKTS:SONVY - Get Free Report) have received a consensus rating of "Moderate Buy" from the eight ratings firms that are currently covering the firm, MarketBeat reports. One analyst has rated the stock with a sell recommendation, four have issued a hold recommendation, one has issued a buy recommendation and two have issued a strong buy recommendation on the company.
Several research firms recently issued reports on SONVY. Zacks Research raised Sonova from a "strong sell" rating to a "hold" rating in a research report on Monday, February 9th. BNP Paribas Exane raised Sonova from a "strong sell" rating to a "strong-buy" rating in a research report on Tuesday, March 10th. Finally, Jefferies Financial Group cut Sonova from a "hold" rating to a "moderate sell" rating in a research report on Wednesday, March 18th.
Check Out Our Latest Research Report on Sonova
Sonova Price Performance
SONVY stock opened at $45.99 on Friday. Sonova has a 12-month low of $42.26 and a 12-month high of $68.76. The company has a quick ratio of 0.91, a current ratio of 1.24 and a debt-to-equity ratio of 0.51. The stock's 50 day simple moving average is $46.75 and its 200 day simple moving average is $50.55.
About Sonova
(
Get Free Report)
Sonova AG OTCMKTS: SONVY is a Switzerland-based provider of hearing care solutions, headquartered in Stäfa. The company designs, develops, manufactures and distributes a range of audiological products and related services aimed at improving hearing and communication for people with hearing loss. Its portfolio spans behind-the-ear and in-the-ear hearing instruments, wireless accessories and software solutions that enable connectivity with consumer devices and audiological fittings.
Sonova markets its products under several well-known brands, including Phonak and Unitron for hearing aids, and it is also associated with Advanced Bionics for cochlear implant systems.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Sonova, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sonova wasn't on the list.
While Sonova currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for May 2026. Learn which stocks have the most short interest and how to trade them. Click the link to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
